We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00698165
Recruitment Status : Completed
First Posted : June 17, 2008
Last Update Posted : February 20, 2009
i3 Innovus
Information provided by:

June 16, 2008
June 17, 2008
February 20, 2009
June 2007
Not Provided
Mini-Mental State Examination (MMSE), Disability Assessment for Dementia Scale (DAD), Neuropsychiatric Inventory Questionnaire (NPI-Q) [ Time Frame: Collected one time only ]
Same as current
Complete list of historical versions of study NCT00698165 on ClinicalTrials.gov Archive Site
  • Resource Utilization in Dementia (RUD) [ Time Frame: collected one time only ]
  • Short Form - 12 domains instrument (SF-12) [ Time Frame: collected one time only ]
  • World Health Organization Quality of Life instrument (WHO-QoL) [ Time Frame: collected one time only ]
  • Zarit Caregiver Burden Interview (ZBI) [ Time Frame: collected one time only ]
  • 15 domains Quality of Life Index instrument (15D) [ Time Frame: collected one time only ]
Same as current
Not Provided
Not Provided
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease
Not Provided
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Adults with Alzheimer's Disease and their informal caregivers are recruited from both outpatient settings and long-term residential care settings
Alzheimer's Disease
Not Provided
  • Patients
    1200 adults with mild to severe Alzheimer's disease
  • Caregivers
    1200 informal caregivers
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
January 2009
Not Provided

Inclusion Criteria:

  • Clinical diagnosis of possible or probable Alzheimer's disease, with or without vascular elements
  • The primary caregiver can be identified
  • The patient and his/her primary caregiver are both willing and able to participate in the study

Exclusion Criteria:

  • Patient or caregiver affected by alcohol or narcotics to the extent that it interferes with the completion of the study
  • Patient or caregiver does not understand English
  • Patient and/ or caregiver is the physician or physician's staff
  • Patient and/ or caregiver is a family member of the physician or physician's staff
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Spain,   Sweden,   United Kingdom,   United States
EHE 1100
Not Provided
Not Provided
Hans-Göran Hårdemark, Medical Science Director, AstraZeneca R&D
i3 Innovus
Study Director: Linus Jönsson i3 Innovus
February 2009